Lawyers at the US Justice Department defied China’s Ministry of Commerce in a brief urging the US Supreme Court to review the dismissal of an antitrust class action against a cartel of Chinese vitamin manufacturers, reported Reuters.
The brief, filed by the US Solicitor General and the Justice Department’s antitrust chief, argues that the 2nd US Circuit Court of Appeals paid too much deference to the Chinese ministry’s characterization of Chinese antitrust law.
The US government recommended the Supreme Court hear the case, Animal Science Products v. Hebei Welcome Pharmaceutical, to clarify how much weight US courts should give to foreign sovereigns’ descriptions of their laws.
The respondents are Chinese manufacturers and exporters of Vitamin C that have been accused of anti-competitive behavior in violation of the Sherman Act. The companies do not contest these allegations but argue that they were compelled to act by Chinese laws and regulations.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Urged to Enforce Rarely Used Antitrust Law Against Retail Giants
Mar 28, 2024 by
CPI
UK’s Fingleton Bolsters Team with New Additions
Mar 28, 2024 by
CPI
Britain’s Competition Regulator Clears Aviva’s Acquisition of AIG Life UK
Mar 28, 2024 by
CPI
White House Implements New AI Safeguards to Protect Rights and Safety
Mar 28, 2024 by
CPI
Denver Court Sets August Date for Kroger-Albertsons Merger Showdown
Mar 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Real Estate & Antitrust
Mar 27, 2024 by
CPI
Systematic National Evidence of Steering by Real Estate Agents
Mar 27, 2024 by
CPI
Compliance Now! Actionable Antitrust Advice for the Residential Real Estate Industry
Mar 27, 2024 by
CPI
Real Estate Commissions: Some Insights from the Economics of Multi-Sided Platforms
Mar 27, 2024 by
CPI
New Ideas for Promoting Real Estate Brokerage Price Competition
Mar 27, 2024 by
CPI